Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus

---

Copy For Citation

Guclu M., Kiyici S., Gul Z., ÇAVUN S.

ENDOCRINE CONNECTIONS, vol.7, no.1, pp.193-198, 2018 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 7 Issue: 1
• Publication Date: 2018
• Doi Number: 10.1530/ec-17-0242
• Journal Name: ENDOCRINE CONNECTIONS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.193-198
• Keywords: exenatide, ghrelin, diabetes, GLYCEMIC CONTROL, INSULIN, WEIGHT, EXENDIN-4, METFORMIN, PEPTIDE, GLP-1, CELL
• Bursa Uludag University Affiliated: Yes

Abstract

Aim: In the present study, we investigated the long-term effects of exenatide treatment on serum fasting ghrelin levels in patients with type 2 diabetes mellitus.